.png)
For many women seeking abortion options and pregnancy termination, the abortion pill may seem like a viable choice. However, there are instances where some women may be ineligible for this method due to various factors and medical considerations. Understanding these limitations is crucial for making informed decisions about reproductive health. We are a pro-woman, holistic, non-profit organization that does not refer for or perform abortion services. However, we understand the unique challenges inherent in pregnancy and are here to inform and empower you with answers and options. Whether you need community referrals or access to additional resources, we are committed to walking with you on your journey toward a healthier you.
The Importance of Eligibility Criteria
Before considering the abortion pill, it's essential to understand the eligibility criteria outlined by medical professionals. These criteria help ensure the safety and effectiveness of the medication while minimizing potential risks and complications.
Here are 10 common reasons why women may be ineligible for the abortion pill:
Duration of Pregnancy. The abortion pill is currently* FDA-approved for pregnancies up to 70 days (10 weeks) after the last menstrual period. Women beyond this time frame are ineligible for the medication, according to the FDA.
Note: This blog was last updated on March 6, 2024. *There is an upcoming court case that may change the legality and approval of mifepristone and the timeline that abortion pills can be taken.
Access to Emergency Medical Care. Due to the nature of the abortion pill regimen, women must have easy access to emergency medical assistance in the two weeks following medication intake. Limited access to medical care may deem some individuals ineligible due to the potential risks and side effects.
Intrauterine Device (IUD). The presence of an intrauterine device (IUD) necessitates its removal before initiating the abortion pill regimen. Failure to remove the IUD may result in complications and render the treatment ineffective.
Ectopic Pregnancy. Women with pregnancies located outside the uterus (ectopic pregnancy) are not eligible for the abortion pill. Ectopic pregnancies require immediate medical attention and intervention. The only way to diagnose an intrauterine pregnancy is through an ultrasound.
Bleeding or Blood-Clotting Disorders. Women with bleeding or blood-clotting disorders, such as hemophilia, may experience complications during the abortion pill process. These conditions warrant careful evaluation and medical supervision.
Allergic Reactions. Women allergic to prostaglandins or any components of the abortion pill should not proceed with the medication. Allergic reactions can range from mild to severe and require immediate medical attention.
Use of Blood Thinner. Individuals taking blood thinners like warfarin (Coumadin, Jantoven) may face increased bleeding risks when combined with the abortion pill. Medical consultation is necessary to assess the compatibility of medications.
Long-Term Steroid Use. Prolonged use of steroid medication may affect the body's response to the abortion pill regimen. Women on long-term steroid therapy should discuss their eligibility for the medicines with healthcare providers.
Adrenal Gland Disorders. Individuals with chronic adrenal failure or disorders affecting the adrenal glands may face increased risks when taking the abortion pill. It is essential to assess adrenal health before proceeding with the medication.
Porphyria. Porphyria, a genetic enzyme disorder impacting the skin or nervous system, poses risks during medication intake. Women with porphyria may be ineligible for the abortion pill due to potential adverse effects.
Empowering Informed Decisions and Next Steps
Understanding the factors that may render some women ineligible for the abortion pill is essential for navigating reproductive health.
If you think you may have one or more of these factors, come see us. You don't have to face this alone. Our center offers the support and resources to make informed decisions about your pregnancy and health.
Take the first step by making an appointment with our professional staff today!
Additional Sources:
American College of Obstetricians and Gynecologists. "Medication Abortion: Up to 70 Days of Gestation." Practice Bulletin, October 2020. Available at: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/10/medication-abortion-up-to-70-days-of-gestation
Mayo Clinic. "Mifepristone (Oral Route) - Side Effects." Mayo Clinic, Accessed December 2023. Available at: https://www.mayoclinic.org/drugs-supplements/mifepristone-oral-route/side-effects/drg-20067123?p=1
Drugs and Conditions. “Misoprostol Side Effects.” Available at: https://www.drugs.com/misoprostol.html
Comments